Markus Friedemann

535 total citations
13 papers, 360 citations indexed

About

Markus Friedemann is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Markus Friedemann has authored 13 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Markus Friedemann's work include Epigenetics and DNA Methylation (5 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Markus Friedemann is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Markus Friedemann collaborates with scholars based in Germany, Australia and Russia. Markus Friedemann's co-authors include Mario Menschikowski, Olga Sukocheva, Gjumrakch Aliev, Jan‐Christoph Simon, Sandra Franz, Matthias Schnabelrauch, W. Pompe, Katja Franke, Liv Kalbitzer and Stephanie Moeller and has published in prestigious journals such as Scientific Reports, Pharmacology & Therapeutics and Seminars in Cancer Biology.

In The Last Decade

Markus Friedemann

12 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Friedemann Germany 8 196 66 65 56 55 13 360
Shifeng Kan China 11 174 0.9× 33 0.5× 98 1.5× 36 0.6× 92 1.7× 26 390
Darrian Bugg United States 8 302 1.5× 42 0.6× 108 1.7× 64 1.1× 84 1.5× 10 625
Nicholas Watson United States 4 187 1.0× 40 0.6× 25 0.4× 29 0.5× 51 0.9× 4 338
Zarema Gilazieva Russia 11 205 1.0× 99 1.5× 47 0.7× 21 0.4× 94 1.7× 17 391
Jessica S. Elman United States 9 134 0.7× 42 0.6× 44 0.7× 20 0.4× 56 1.0× 9 320
Mary C. Whelan United States 10 274 1.4× 45 0.7× 46 0.7× 103 1.8× 49 0.9× 13 496
Charlotte E. Severn United Kingdom 8 136 0.7× 65 1.0× 86 1.3× 58 1.0× 34 0.6× 10 374
Caroline Hilmi France 8 296 1.5× 27 0.4× 43 0.7× 69 1.2× 99 1.8× 8 407
Katie Glen United Kingdom 9 186 0.9× 68 1.0× 33 0.5× 34 0.6× 41 0.7× 21 323
Stefan Przyborski United Kingdom 8 329 1.7× 79 1.2× 40 0.6× 17 0.3× 37 0.7× 16 526

Countries citing papers authored by Markus Friedemann

Since Specialization
Citations

This map shows the geographic impact of Markus Friedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Friedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Friedemann more than expected).

Fields of papers citing papers by Markus Friedemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Friedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Friedemann. The network helps show where Markus Friedemann may publish in the future.

Co-authorship network of co-authors of Markus Friedemann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Friedemann. A scholar is included among the top collaborators of Markus Friedemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Friedemann. Markus Friedemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Friedemann, Markus, F. Harder, & Gerd Wachsmuth. (2023). Finding global solutions of some inverse optimal control problems using penalization and semismooth Newton methods. Journal of Global Optimization. 86(4). 1025–1061.
3.
Drukewitz, Stephan, Susan Richter, Markus Friedemann, et al.. (2022). Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model. Cells. 11(3). 560–560. 2 indexed citations
4.
Ullrich, Martin, Susan Richter, Stephan Drukewitz, et al.. (2022). Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models. Theranostics. 13(1). 278–294. 7 indexed citations
5.
Friedemann, Markus, Nicole Bechmann, Olga Sukocheva, et al.. (2021). Increased Sensitivity of Detection of RASSF1A and GSTP1 DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCR. Cancers. 13(17). 4459–4459. 11 indexed citations
6.
Friedemann, Markus, et al.. (2020). Methylation of the Phospholipase A2 Receptor 1 Promoter Region in Childhood B Cell Acute Lymphoblastic Leukaemia. Scientific Reports. 10(1). 9058–9058. 7 indexed citations
7.
Sukocheva, Olga, Elena Lukina, Markus Friedemann, et al.. (2020). The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives. Seminars in Cancer Biology. 82. 35–59. 56 indexed citations
8.
Sukocheva, Olga, Hideki Furuya, Mah Lee Ng, et al.. (2019). Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacology & Therapeutics. 207. 107464–107464. 109 indexed citations
9.
Friedemann, Markus, Albert Hagelgans, Nicole Bechmann, et al.. (2018). Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growthin vitroandin vivo. Oncotarget. 9(89). 35983–35996. 7 indexed citations
10.
11.
Menschikowski, Mario, et al.. (2018). Identification and Quantification of Heterogeneously-methylated DNA Fragments Using Epiallele-sensitive Droplet Digital Polymerase Chain Reaction (EAST-ddPCR). Cancer Genomics & Proteomics. 15(4). 299–312. 4 indexed citations
12.
Hagelgans, Albert, et al.. (2017). Identification of CpG Sites of SERPINA5 Promoter with Opposite Methylation Patterns in Benign and Malignant Prostate Cells. Anticancer Research. 37(12). 6609–6618. 4 indexed citations
13.
Friedemann, Markus, Liv Kalbitzer, Sandra Franz, et al.. (2017). Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks. Advanced Healthcare Materials. 6(7). 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shifeng Kan Breakdown of academic impact, for papers by Darrian Bugg Breakdown of academic impact, for papers by Nicholas Watson Breakdown of academic impact, for papers by Zarema Gilazieva Breakdown of academic impact, for papers by Jessica S. Elman Breakdown of academic impact, for papers by Mary C. Whelan Breakdown of academic impact, for papers by Charlotte E. Severn Breakdown of academic impact, for papers by Caroline Hilmi Breakdown of academic impact, for papers by Katie Glen Breakdown of academic impact, for papers by Stefan Przyborski
Rankless by CCL
2026